224 related articles for article (PubMed ID: 38167072)
1. Identification of a novel lymphangiogenesis signature associated with immune cell infiltration in colorectal cancer based on bioinformatics analysis.
Liu H; Shi H; Sun Y
BMC Med Genomics; 2024 Jan; 17(1):2. PubMed ID: 38167072
[TBL] [Abstract][Full Text] [Related]
2. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
4. Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.
Chen L; Ge M; Mo S; Shi M; Zhang J; Liu J
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38362684
[TBL] [Abstract][Full Text] [Related]
5. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
7. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
8. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis.
Liu Q; Liao L
Autoimmunity; 2024 Dec; 57(1):2321908. PubMed ID: 38466182
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
10. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
11. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
Front Genet; 2022; 13():851373. PubMed ID: 35401707
[No Abstract] [Full Text] [Related]
12. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
Front Genet; 2022; 13():1054152. PubMed ID: 36506313
[No Abstract] [Full Text] [Related]
13. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
14. Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer.
Liu X; Li D; Gao W; Zhao W; Jin L; Chen P; Liu H; Zhao Y; Dong G
Front Genet; 2023; 14():1202849. PubMed ID: 37876593
[No Abstract] [Full Text] [Related]
15. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
16. Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis.
Xie Y; Li J; Tao Q; Wu Y; Liu Z; Zeng C; Chen Y
J Cancer; 2024; 15(10):3199-3214. PubMed ID: 38706895
[No Abstract] [Full Text] [Related]
17. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
19. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
20. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]